Good Distribution Practice (GDP) compliance in pharmaceutical distribution is no longer a choice. It is a licence to operate. Analysis of 48 GDP inspections conducted within the European Union showed that 50 percent of these inspections were directly linked to authorisation-related activities. Inspection trends consistently reveal recurring weaknesses in cold chain monitoring, supplier qualification governance, and documentation integrity.
Lenus Health operates with full GDP compliance from Germany. We hold a valid WDA and provide complete GDP-compliant documentation for every shipment to the Middle East, Central Asia, and Latin America. Our familiarity with GDP requirements means we can provide documentation that meets the standards of both our clients’ quality teams and regulatory authorities in destination markets.
In this article we explain what GDP is, what it requires, why it matters for international importers and distributors, and how to distinguish a supplier with genuine GDP compliance from one that only claims it.
Table of Contents
- What GDP Is and Why It Matters in Pharmaceutical Distribution
- The Legal Framework for GDP in the European Union
- Five Core Principles of GDP in Pharmaceutical Distribution
- Operational Requirements of GDP
- GDP Inspections: What Inspectors Look For
- GDP and International Markets
- The Role of Lenus Health in GDP Compliance
- How to Verify a Supplier’s GDP Compliance
- Conclusion
- Frequently Asked Questions
1. What GDP Is and Why It Matters in Pharmaceutical Distribution
Good Distribution Practice (GDP) is a quality system that governs the distribution of medicinal products for human use. It ensures that medicines are consistently stored, transported, and handled under suitable conditions, as required by regulators such as the European Medicines Agency (EMA) and the World Health Organization (WHO).
GDP matters because distribution gaps can degrade medicines, lead to recalls, or result in regulatory action. For pharmaceutical logistics professionals, GDP compliance is a licence to operate, not a choice.
For international importers and distributors, GDP carries additional significance. A European supplier with genuine GDP compliance means that every shipment you receive comes with complete documentation, full batch traceability, and documented quality assurance. This documentation carries significant weight in registration and customs clearance processes in the Middle East, Central Asia, and Latin America.
2. The Legal Framework for GDP in the European Union
The EU GDP guidelines for human medicines — the Guidelines of 5 November 2013 on Good Distribution Practice of Medicinal Products for Human Use, reference 2013/C 343/01 — establish standards for the proper handling, storage, and transport of medicinal products. Compliance with these guidelines is a prerequisite for obtaining and maintaining a wholesale distribution authorisation.
Anyone engaged in wholesale distribution of medicinal products in the European Economic Area (EEA) must hold a wholesale distribution authorisation issued by the national competent authority of the member state where they operate. After inspecting a wholesale distributor, EU competent authorities issue a GDP certificate or a non-compliance statement, which is entered in the EudraGMDP database.
This means the GDP certificate of every European distributor is publicly verifiable. This transparency is one of the key advantages of sourcing from Europe for international buyers.
3. Five Core Principles of GDP in Pharmaceutical Distribution
The EU GDP guidelines are comprehensive and detailed, but they rest on five main pillars that every international buyer should understand:
- Quality management system: Maintaining a quality management system is critical. Companies must ensure their products always meet quality standards before they are stored or distributed.
- Documentation: Transparency is key. Companies must document their distribution processes so that the source of any potential problems can be identified.
- Temperature control and transport: Strict requirements apply to transport equipment and vehicles. This includes temperature controls, regular monitoring, risk assessments, and planning to prevent any events that could affect product quality.
- Responsible Person: A key element of GDP is the appointment of a Responsible Person who ensures that all GDP-relevant processes are followed.
- Risk-based approach: A central principle of GDP is the risk-based approach, aligned with quality risk management principles.
Together, these five principles create a comprehensive quality system that covers every stage of pharmaceutical distribution.
4. Operational Requirements of GDP
GDP requires the formal designation of a Responsible Person with the authority and qualifications to ensure GDP compliance. The operational requirements fall into four main areas:
- Warehousing: Differentiated areas for reception, quarantine, storage, preparation, and dispatch; thermal mapping of warehouses; sensor calibration and maintenance of critical equipment; access control and cleaning.
- Temperature monitoring: Continuous monitoring according to the marketing authorisation holder’s specifications; alarms, deviation management, and product quality impact assessment; route and packaging qualification for transport.
- Supplier qualification: Technical contracts with carriers and warehousing companies; supplier qualification and audits; recording of in-transit conditions and evaluation of thermal excursions.
- Documentation and data integrity: Inspectors expect complete traceability across mapping, monitoring, and calibration. Data integrity is a central focus in GDP inspections.
These operational requirements together ensure that every pharmaceutical shipment is traceable and documented throughout the entire distribution chain.
5. GDP Inspections: What Inspectors Look For
Regulatory inspections do not fail because policies are missing. They fail when operational controls break down. Inspectors assess how consistently teams execute controls across storage, transport, deviation handling, and documentation management.
The most commonly recurring GDP inspection findings:
- Incomplete or discontinuous temperature reports
- Calibration records not linked to specific devices
- Incomplete training records
- Deviation documentation without clear Corrective and Preventive Action (CAPA)
- Supplier qualification files that have not been updated
For international buyers, these findings matter because they indicate which areas of GDP compliance are most prone to failure. A supplier with weaknesses in these areas can cause delays in customs clearance or regulatory problems in the destination country.
6. GDP and International Markets
EU GDP has strategic importance in international markets. Regulatory authorities in the Middle East, Central Asia, and Latin America look to EU GDP as the reference standard.
- Middle East and GCC: The Saudi Food and Drug Authority (SFDA) and UAE Health Authority require suppliers to provide valid GDP certificates. GDP documentation from German competent authorities carries significant weight in these markets.
- Central Asia: Kazakhstan and Uzbekistan are aligning their requirements with international standards including EU GDP. Uzbekistan’s new EU fast-track registration pathway is built on this alignment.
- Latin America: ANVISA in Brazil has comparable GDP documentation requirements and expects European suppliers to provide complete GDP-compliant documentation.
This global alignment with EU GDP standards means that a European supplier with genuine GDP compliance can provide acceptable documentation across all of these markets.
7. The Role of Lenus Health in GDP Compliance
Lenus Health operates with full GDP compliance from Germany. Our WDA was issued by the German state competent authority and our distribution operations comply with EU GDP guidelines.
Our GDP compliance covers:
- Temperature and humidity-controlled storage with continuous monitoring in our German warehouses
- Continuous temperature monitoring with alarm systems
- Complete batch documentation for every shipment
- A designated Responsible Person who approves all distribution operations
- Regular internal and external inspections
If your procurement or quality team needs to review our GDP documentation or conduct an audit, we welcome that. Transparency with supply partners is something we consider non-negotiable. Pharmaceutical procurement from Europe requires a partner with genuine GDP compliance. If your organisation needs medicines from Germany, the Lenus Health team is ready to provide complete documentation from the very first order.
8. How to Verify a Supplier’s GDP Compliance
Verifying the GDP compliance of a European supplier follows specific steps that every international buyer should know:
- Check EudraGMDP: The EudraGMDP database contains information on GDP and GMP certificates. The GDP certificate of every European distributor is publicly verifiable in this database.
- Request the GDP certificate: The certificate should be from the most recent inspection and issued by a recognised state or national competent authority.
- Review batch documentation samples: A supplier with genuine GDP compliance should be able to show a complete sample documentation package including CoA, temperature report, and batch release records before the first order.
- Ask about the Responsible Person: Every GDP-compliant distributor must have a designated Responsible Person whose details are available.
- Request an audit: A genuinely GDP-compliant partner will welcome an audit. If a supplier refuses one, this is a warning sign.
If your organisation requires GDP-compliant pharmaceutical distribution services from Europe, we welcome the opportunity to discuss your specific requirements.
Conclusion
GDP compliance is no longer only about moving products. It is about protecting market access. For international importers and distributors sourcing medicines from Europe, a supplier’s GDP compliance directly affects their ability to register products, clear customs, and maintain relationships with local regulatory authorities.
The most important point to remember: GDP compliance is not a statement. It is a verifiable certificate. The GDP certificate of every European distributor is public in EudraGMDP. Check it before any supply relationship begins.
GDP inspections returned to normal frequency in 2025 after COVID-19 temporary extensions expired. This means more regular and rigorous inspections that identify weaker suppliers. For international buyers, this is actually good news: the inspection cycle keeps the market honest.
Lenus Health operates with full GDP compliance from Germany. We hold a valid WDA, have a designated Responsible Person, and provide complete batch documentation for every shipment. If your quality or procurement team wants to review our GDP documentation or conduct an audit, we welcome that. Pharmaceutical procurement from Europe requires a partner whose GDP compliance is genuine and documented. The Lenus Health team is ready.
Frequently Asked Questions
- What is GDP in pharmaceutical distribution?
Good Distribution Practice (GDP) is a set of EU guidelines that ensure medicines are consistently stored, transported, and handled under suitable conditions. These guidelines cover the handling, storage, and transport of medicines from purchase through to supply or export. - What is the difference between GDP and GMP?
Good Manufacturing Practice (GMP) governs pharmaceutical manufacturing activities, while GDP follows directly from GMP and covers all storage, transport, and distribution activities. A complete pharmaceutical supply chain requires compliance with both. - Why does GDP compliance matter for international importers?
A European supplier’s GDP compliance directly affects an importer’s ability to register products in the destination country, clear customs, and maintain relationships with local regulatory authorities. Regulatory authorities in the Middle East, Central Asia, and Latin America look to EU GDP as the reference standard. - How can you verify a European supplier’s GDP compliance?
The GDP certificate of every European distributor is publicly verifiable in the EudraGMDP database. You can also request a sample documentation package from the supplier and, where needed, conduct an audit. - Is EU GDP accepted in markets outside Europe?
Yes, EU GDP is widely recognised in international markets as the reference standard. SFDA in Saudi Arabia, UAE Health Authority, Central Asian competent authorities, and ANVISA in Brazil all expect suppliers to provide valid GDP certificates. - What is the difference between WDA and a GDP certificate?
A Wholesale Dealer Authorisation (WDA) is the operating licence for pharmaceutical wholesale distribution, issued by the national or state competent authority. A GDP certificate is the result of an inspection confirming that the distributor’s operations comply with GDP guidelines. Both are required for a qualified distributor.
